Insider Transactions in Q1 2024 at Graphite Bio, Inc. (GRPH)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 21
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
64,971
+8.55%
|
$974,565
$15.03 P/Share
|
|
Mar 21
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
933,038
+21.94%
|
$13,995,570
$15.03 P/Share
|
|
Mar 21
2024
|
Ra Capital Management, L.P. |
BUY
Grant, award, or other acquisition
|
Indirect |
3,245,785
+50.0%
|
-
|
|
Mar 21
2024
|
James W Mccollum Director |
BUY
Grant, award, or other acquisition
|
Indirect |
494,233
+26.63%
|
$3,459,631
$7.52 P/Share
|
|
Mar 21
2024
|
James W Mccollum Director |
BUY
Grant, award, or other acquisition
|
Direct |
95,034
+50.0%
|
-
|
|
Mar 21
2024
|
Marc Odrich Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
99,599
+50.0%
|
-
|
|
Mar 21
2024
|
Versant Venture Capital Vi, L.P. |
BUY
Other acquisition or disposition
|
Indirect |
598,203
+41.53%
|
-
|